Evaluating the Symbicort Turbuhaler [Formoterol/Budesonide] Maintenance and Reliever Therapy for Asthma in Daily Practice.
Phase of Trial: Phase IV
Latest Information Update: 24 Jul 2009
At a glance
- Drugs Budesonide/formoterol (Primary)
- Indications Asthma
- Focus Therapeutic Use
- Sponsors AstraZeneca
- 24 Jul 2009 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 24 Jul 2009 Actual end date (Apr 2009) added as reported by ClinicalTrials.gov.
- 16 Nov 2008 New trial record.